VTVT - vTvセラピュ―ティクス (vTv Therapeutics Inc.) vTvセラピュ―ティクス

 VTVTのチャート


 VTVTの企業情報

symbol VTVT
会社名 vTv Therapeutics Inc (vTvセラピュ―ティクス)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 vTv・セラピュティクス(vTv Therapeutics Inc.)は臨床段階のバイオ医薬品会社である。同社は経口投与小分子薬物候補の発見・開発に従事する。アルツハイマー病(AD)の治療薬候補はアゼリラゴン(TTP488)であり、これは第III相臨床試験に患者登録を開始した糖化最終生成物(RAGE)の受容体を標的とする経口投与小分子拮抗薬である。II型糖尿病薬候補には、第IIb相臨床試験の登録を完了した経口投与肝臓選択性グルコキナーゼ活性化因子(GKA)であるTTP399、及び第II相臨床試験に登録を開始したグルカゴン様ペプチド-1受容体(GLP-1r)を標的とする経口投与非ペプチドアゴニストであるTTP273を含む。同社は筋肉衰弱の予防および炎症性障害の治療用、臨床開発の各段階における3つの追加プログラムを有する。   vTvセラピュ―ティクスは米国のバイオ医薬品企業。臨床段階で、経口投与できる低分子の分子標的薬の発見、開発に従事する。主要なパイプライン薬剤はアルツハイマ―病治療薬「Azeliragon(TTP488)」、2型糖尿病治療薬「TTP399」などを含む。また、筋力低下防止の治療薬や炎症性疾患の治療薬も開発する。本社はノ―スカロライナ州。   vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC.
本社所在地 4170 Mendenhall Oaks Pkwy High Point NC 27265 USA
代表者氏名 Jeffrey B. Kindler ジェフリー・B・キンドラー
代表者役職名 Executive Chairman of the Board 取締役会長
電話番号 +1 336-841-0300
設立年月日 42095
市場名 NASDAQ Small Cap
ipoyear 2015年
従業員数 56人
url www.vtvtherapeutics.com
nasdaq_url https://www.nasdaq.com/symbol/vtvt
adr_tso
EBITDA EBITDA(百万ドル) -42.13100
終値(lastsale) 3.04
時価総額(marketcap) 118154676.8
時価総額 時価総額(百万ドル) 117.07870
売上高 売上高(百万ドル) 4.78500
企業価値(EV) 企業価値(EV)(百万ドル) 135.00770
当期純利益 当期純利益(百万ドル) -8.13800
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 vTv Therapeutics Inc revenues increased from $43K to $4.5M. Net loss decreased 26% to $6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Stock-based Compensation in R&D decrease of 7% to $624K (expense) Other income increase from $0K to $36K (income).

 VTVTのテクニカル分析


 VTVTのニュース

   Has vTv Therapeutics (VTVT) Outpaced Other Medical Stocks This Year?  2020/03/12 15:30:09 Zacks Investment Research
Is (VTVT) Outperforming Other Medical Stocks This Year?
   vTv Therapeutics Inc. (VTVT) Shares March Higher, Can It Continue?  2020/02/24 16:24:00 Zacks Investment Research
As of late, it has definitely been a great time to be an investor in vTv Therapeutics Inc. (VTVT).
   VTV Therapeutics 'Close To The Finish Line' On What FDA, Diabetes Patients Want: An Adjunct Therapy To Insulin  2020/02/19 10:48:00 Benzinga
Steve Holcombe transitioned from telecom to biotech back when vTv Therapeutics Inc (NASDAQ: VTVT) was just a startup. Now, 18 years in, he’s finally …
   The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology  2020/02/11 12:23:06 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 10) AbbVie Inc (NYSE: ABBV ) Allergan plc (NYSE: AGN ) )(reacted to better-than-expected results and comments that its deal to be acquired by AbbVie is on track to close by the first quarter) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Aptose Biosciences Inc (NASDAQ: APTO ) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Ascendis Pharma A/S (NASDAQ: ASND ) AtriCure Inc. (NASDAQ: ATRC ) ChemoCentryx Inc (NASDAQ: CCXI ) Co-Diagnostics Inc (NASDAQ: CODX )(announced sales of its new coronavirus test ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) DexCom, Inc. (NASDAQ: DXCM ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fulgent Genetics Inc (NASDAQ: FLGT ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Insulet Corporation (NASDAQ: PODD ) Kodiak Sciences Inc (NASDAQ: KOD )(reacted to positive data readout from early-stage study of experimental drug to treat eye disorders) Masimo Corporation (NASDAQ: MASI ) Novartis AG (NYSE: NVS ) Pacira Biosciences Inc (NASDAQ: PCRX ) Principia Biopharma Inc (NASDAQ: PRNB ) PTC Therapeutics, Inc (NASDAQ: PTCT ) Revance Therapeutics Inc (NASDAQ: RVNC ) ResMed Inc.
   VTV Therapeutics Shares Hit Multi-Year Highs After Diabetes Drug Aces Midphase Study  2020/02/10 16:14:32 Benzinga Feeds
Shares of micro-cap biotech vTv Therapeutics Inc (NASDAQ: VTVT ) were advancing to their highest level since October 2018 Monday following a clinical readout … Full story available on Benzinga.com
   vTv Therapeutics Inc. (VTVT) Shares March Higher, Can It Continue?  2020/02/24 16:24:00 Zacks Investment Research
As of late, it has definitely been a great time to be an investor in vTv Therapeutics Inc. (VTVT).
   VTV Therapeutics 'Close To The Finish Line' On What FDA, Diabetes Patients Want: An Adjunct Therapy To Insulin  2020/02/19 10:48:00 Benzinga
Steve Holcombe transitioned from telecom to biotech back when vTv Therapeutics Inc (NASDAQ: VTVT) was just a startup. Now, 18 years in, he’s finally …
   The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology  2020/02/11 12:23:06 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 10) AbbVie Inc (NYSE: ABBV ) Allergan plc (NYSE: AGN ) )(reacted to better-than-expected results and comments that its deal to be acquired by AbbVie is on track to close by the first quarter) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Aptose Biosciences Inc (NASDAQ: APTO ) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Ascendis Pharma A/S (NASDAQ: ASND ) AtriCure Inc. (NASDAQ: ATRC ) ChemoCentryx Inc (NASDAQ: CCXI ) Co-Diagnostics Inc (NASDAQ: CODX )(announced sales of its new coronavirus test ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) DexCom, Inc. (NASDAQ: DXCM ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fulgent Genetics Inc (NASDAQ: FLGT ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Insulet Corporation (NASDAQ: PODD ) Kodiak Sciences Inc (NASDAQ: KOD )(reacted to positive data readout from early-stage study of experimental drug to treat eye disorders) Masimo Corporation (NASDAQ: MASI ) Novartis AG (NYSE: NVS ) Pacira Biosciences Inc (NASDAQ: PCRX ) Principia Biopharma Inc (NASDAQ: PRNB ) PTC Therapeutics, Inc (NASDAQ: PTCT ) Revance Therapeutics Inc (NASDAQ: RVNC ) ResMed Inc.
   VTV Therapeutics Shares Hit Multi-Year Highs After Diabetes Drug Aces Midphase Study  2020/02/10 16:14:32 Benzinga Feeds
Shares of micro-cap biotech vTv Therapeutics Inc (NASDAQ: VTVT ) were advancing to their highest level since October 2018 Monday following a clinical readout … Full story available on Benzinga.com
   Vtv Therapeutics up 67% premarket on positive TTP399 data  2020/02/10 12:29:47 Seeking Alpha
Thinly traded micro cap vTv Therapeutics (NASDAQ:VTVT) jumps 67% premarket on robust volume on the heels of positive results from Part 2 of a Phase 2 clini
   VTV Therapeutics 'Close To The Finish Line' On What FDA, Diabetes Patients Want: An Adjunct Therapy To Insulin  2020/02/19 10:48:00 Benzinga
Steve Holcombe transitioned from telecom to biotech back when vTv Therapeutics Inc (NASDAQ: VTVT) was just a startup. Now, 18 years in, he’s finally …
   The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology  2020/02/11 12:23:06 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 10) AbbVie Inc (NYSE: ABBV ) Allergan plc (NYSE: AGN ) )(reacted to better-than-expected results and comments that its deal to be acquired by AbbVie is on track to close by the first quarter) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Aptose Biosciences Inc (NASDAQ: APTO ) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Ascendis Pharma A/S (NASDAQ: ASND ) AtriCure Inc. (NASDAQ: ATRC ) ChemoCentryx Inc (NASDAQ: CCXI ) Co-Diagnostics Inc (NASDAQ: CODX )(announced sales of its new coronavirus test ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) DexCom, Inc. (NASDAQ: DXCM ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fulgent Genetics Inc (NASDAQ: FLGT ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Insulet Corporation (NASDAQ: PODD ) Kodiak Sciences Inc (NASDAQ: KOD )(reacted to positive data readout from early-stage study of experimental drug to treat eye disorders) Masimo Corporation (NASDAQ: MASI ) Novartis AG (NYSE: NVS ) Pacira Biosciences Inc (NASDAQ: PCRX ) Principia Biopharma Inc (NASDAQ: PRNB ) PTC Therapeutics, Inc (NASDAQ: PTCT ) Revance Therapeutics Inc (NASDAQ: RVNC ) ResMed Inc.
   VTV Therapeutics Shares Hit Multi-Year Highs After Diabetes Drug Aces Midphase Study  2020/02/10 16:14:32 Benzinga Feeds
Shares of micro-cap biotech vTv Therapeutics Inc (NASDAQ: VTVT ) were advancing to their highest level since October 2018 Monday following a clinical readout … Full story available on Benzinga.com
   Vtv Therapeutics up 67% premarket on positive TTP399 data  2020/02/10 12:29:47 Seeking Alpha
Thinly traded micro cap vTv Therapeutics (NASDAQ:VTVT) jumps 67% premarket on robust volume on the heels of positive results from Part 2 of a Phase 2 clini
   vTv Therapeutics Announces Positive Results from Part 2 of the Phase 2 Simplici-T1 Study of TTP399, Potential First-in-Class Oral Adjunctive Therapy for Patients with Type 1 Diabetes  2020/02/10 12:00:10 Yahoo Finance
HIGH POINT, N.C., Feb. 10, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (VTVT) today announced positive results from Part 2 of the Phase 2 Simplici-T1 trial assessing TTP399 as an oral adjunctive therapy to insulin in adults with type 1 diabetes (T1D). The 12-week trial investigated the efficacy

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 vTvセラピュ―ティクス VTVT vTv Therapeutics Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)